Successful treatment of a patient with adult food allergy and severe asthma using omalizumab

Miyuki Nishie, Katsunori Masaki, Shinichi Okuzumi, Takao Mochimaru, Hiroki Kabata, Jun Miyata, Hayato Takahashi, Koichi Fukunaga

研究成果: Article査読

4 被引用数 (Scopus)


Food allergy is a typical immediate-onset allergic disease in which symptoms are provoked by exposure to the sensitized antigens. Although previous reports have shown that omalizumab has helped children with egg or milk allergy achieve oral immunotherapy safely, there is still no established method for induction of remission in adult food allergy. A 51-year-old woman with oral steroid-dependent severe asthma was treated with omalizumab for 6 years. She had shellfish and wheat food allergy and oral allergy syndrome induced by kiwi and other foods associated with latex-fruit syndrome. Since omalizumab treatment, her food allergy symptoms had disappeared. After 7 years of this treatment, disseminated erythema suddenly appeared; omalizumab was discontinued because of suspected drug-induced eruption. After omalizumab interruption, she felt an itching sensation in her throat with worsened asthma control immediately after wheat ingestion. Readministration of omalizumab improved these symptoms. Thus, we raised the possibility that omalizumab not only improved asthma control but also induced pharmacological remission of the patient's food allergy. Omalizumab may be considered as a treatment option for adult patients with food allergies and severe asthma.

ジャーナルAsia Pacific Allergy
出版ステータスPublished - 2021 7月

ASJC Scopus subject areas

  • 免疫アレルギー学
  • 皮膚病学


「Successful treatment of a patient with adult food allergy and severe asthma using omalizumab」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。